Analyzing the Distribution of Mutations for Glycogen Storage Disease Type 1a in Turkey and Suggested Gene Therapy Methods for It
G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a - ScienceDirect
G6PC Antibody - N-terminal region (ARP44224_P050) | Aviva Systems Biology | Aviva Systems Biology
Diagram of the molecular mechanism of G6pc gene regulation by glucose... | Download Scientific Diagram
Diagram illustrating the regulation of G6PC in (a) normal physiological... | Download Scientific Diagram
Recent development and gene therapy for glycogen storage disease type Ia
G6PC indicated poor prognosis in cervical cancer and promoted cervical carcinogenesis in vitro and in vivo | Reproductive Biology and Endocrinology | Full Text
Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia
Rat G6PC shRNA Plasmid | Abbexa Ltd
Nutrients | Free Full-Text | Genistein Alleviates High-Fat Diet-Induced Obesity by Inhibiting the Process of Gluconeogenesis in Mice
A novel homozygous no-stop mutation in G6PC gene from a Chinese patient with glycogen storage disease type Ia - ScienceDirect
Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes | PNAS
Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editing: Molecular Therapy
Projects | Molecular Basis of Genetic Diseases | Vanderbilt University
Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia | Orphanet Journal of Rare Diseases | Full Text
The G6PC gene and the encoded G6Pase-a enzyme. (A) G6PC, located on... | Download Scientific Diagram
Aviva Systems Biology Corp G6pc Antibody - N-terminal region (ARP44223_P050) | Fisher Scientific
Anti-G6PC Antibody | Suitable for WB IF | Highly Sensitive